Understanding how the reticulospinal system controls movement
Official title: Contributions of the Reticulospinal System to Movement Control and Functional Recovery in Patients With Spinal Cord Injury
Run by University of Zurich · NCT04967274 · Data updated 2026-11-12
This study is testing how a part of the nervous system helps people with spinal cord injuries move by using surprising sounds to see how quickly they can react and move.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 248 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich) |
| Status | Recruiting |
| Started | January 15, 2022 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT04967274 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with spinal cord injuries classified as ASIA Impairment scale A-D and healthy participants.
✕Probably not a fit
Patients with current neurological or orthopedic problems affecting movement may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the role of the reticulospinal system in controlling movements, particularly in individuals with spinal cord injuries. It utilizes the StartReact paradigm, which involves startling acoustic stimuli to assess the motor control capabilities of the reticulospinal pathways. By examining the reaction times and movement execution in response to these stimuli, the study aims to enhance our understanding of motor physiology in humans, especially in the context of spinal cord injuries. The findings could provide insights into rehabilitation strategies for affected individuals.
Why it matters
Potential benefit: If successful, this study could lead to improved rehabilitation techniques for patients with spinal cord injuries.
How similar studies have gone: While the reticulospinal system has been studied in animals, this approach in humans is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent as documented by signature For SCI patients: * ASIA Impairment scale (AIS) A-D * Focal damage at cervical (C4-C7; i.e. damage rostral of the spi-nal segments innervating the examined hand and leg muscles) or thoracic (T4-T12; i.e. damage caudal of the spinal segments innervating the m. abductor digiti minimi, but rostral of the spi-nal segments innervating the m. tibialis anterior) * Patients with cervical SCI must reveal bilaterally intact ulnar nerves as demonstrated by normal compound motor action potential (cMAP), nerve conduction velocity (NCV) and F-wave latencies in clinical neurography. * Patients with thoracic SCI must reveal bilaterally intact tibial and peroneal nerves as demonstrated by normal cMAP, NCV and F-wave latencies Exclusion Criteria: * Women who are pregnant or breast feeding * Current neurological problems other than SCI and related impairments * Current orthopaedic problems affecting upper and lower extremity movements * History of alcohol abuse or the intake of psychotropic drugs * History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV)) * History of major pulmonary condition (e.g., chronic obstructive pulmonary disease (GOLD II-IV)) * Current major depression or psychosis * Fever of unknown origin
Where it's running
-
Balgrist University Hospital
Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Patrick Freund, Prof. Dr. — University of Zurich
- Study coordinator: Linard Filli, Dr.
- Email: linard.filli@balgrist.ch
- Phone: +41 44 510 72 12
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury
This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.
-
NG004 for incomplete cervical spinal cord injury
This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.
-
Robot-assisted training for arm and leg movement after stroke or injury
This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.
-
ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab
This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.
-
Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury
This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.
-
Hybrid HIIT-FES cycling program for people with spinal cord injury
This study tests a hybrid exercise program that combines functional electrical stimulation cycling with voluntary arm work to improve health in adults with spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.